Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Stop of proton-pump inhibitor treatment in patients with liver cirrhosis
DRKS00021290Phase 3Recruiting
- Sponsor
- University Medical Center Hamburg-Eppendorf
- Start
- Mar 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in Cirrhosis comparing Continued esomeprazole with Discontinued esomeprazole (placebo) (2 arms). Started Mar 2021; status: recruiting.
02
Drugs
esomeprazole
03
Conditions
Cirrhosis
Beyond the preview
Go deeper on DRKS00021290.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on DRKS00021290.